[Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
Chemotherapy-induced cardiotoxicity is a major cause of morbidity and mortality in cancer survivor. The most clinically evident and best known cardiotoxicity is the anthracycline adverse effect with heart failure. Many cardiovascular adverse effects appear after cancer therapy: heart congestive failure, myocardial ischemia, hypertension, thromboembolic complications, arrhythmias and conduction disturbances. There are potential strategies to mitigate the risks of cardiac complications for cancer patients with physical examination, echocardiography and electrocardiogram. The management of the cardiotoxicity is variable.
Hôpital cardiologique du Haut Lévêque, service des cardiopathies congénitales de l'enfant et de l'adulte, Bordeaux-Pessac, France. Electronic address: marie.veniard@orange.fr.
Marie
M
Nelson-Veniard
Hôpital cardiologique du Haut Lévêque, service des cardiopathies congénitales de l'enfant et de l'adulte, Bordeaux-Pessac, France.
Jean-Benoit
JB
Thambo
D018943:Anthracyclines / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced; D066126:Cardiotoxicity; D002675:Child, Preschool; D006331:Heart Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D006333:Heart Failure / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D015994:Incidence; D017202:Myocardial Ischemia / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents
Cardiotoxicity; Cardiotoxicité; Chemotherapy; Children; Chimiothérapie; Enfant